Empresa Acumen Pharmaceuticals, Inc.
Acciones
ABOS
US00509G2093
Biotecnología e investigación médica
Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
3,345 USD | +3,88 % | +4,40 % | -13,54 % |
Resumen de negocios
Número de empleados: 52
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Daniel O'Connell
CEO | Chief Executive Officer | 54 | 01/04/06 |
Jim Doherty
PSD | President | 56 | 01/02 |
Matthew Zuga
DFI | Director of Finance/CFO | 58 | 01/05/21 |
Kasey Spencer
CTO | Chief Tech/Sci/R&D Officer | - | - |
Russell Barton
COO | Chief Operating Officer | 66 | 01/04/19 |
Eric Siemers
CTO | Chief Tech/Sci/R&D Officer | 68 | 01/06/18 |
Alexandria Braun
IRC | Investor Relations Contact | - | 01/09/22 |
Kathleen Pierce
PRN | Corporate Officer/Principal | - | - |
Amber Dilley
PRN | Corporate Officer/Principal | - | 01/01/21 |
Jasna Jerecic
PRN | Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Daniel O'Connell
CEO | Chief Executive Officer | 54 | 01/04/06 |
Director/Board Member | 55 | 01/04/22 | |
Jeffrey Ives
BRD | Director/Board Member | 73 | 01/05/14 |
Sean Stalfort
BRD | Director/Board Member | 54 | 01/10/18 |
Derrell Porter
BRD | Director/Board Member | 53 | 04/01/23 |
Laura Stoppel
BRD | Director/Board Member | 38 | 01/11/20 |
Nathan Fountain
BRD | Director/Board Member | 61 | 01/06/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 60 079 778 | 54 596 907 ( 90,87 %) | 0 | 90,87 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-13,54 % | 193 M | |
+1,78 % | 42,19 mil M | |
+44,30 % | 40,15 mil M | |
-6,20 % | 28,31 mil M | |
+7,43 % | 24,63 mil M | |
-21,63 % | 18,2 mil M | |
+30,19 % | 12,01 mil M | |
-0,58 % | 11,76 mil M | |
+15,38 % | 10,4 mil M | |
-3,71 % | 9936,09 M |
- Bolsa de valores
- Acciones
- Acción ABOS
- Empresa Acumen Pharmaceuticals, Inc.